🏢
AbbVie
ABBV · sp500
$285.19
+0.14% today
$217.72
Open
$285.76
High
$278.01
Low
$381.10B
Market cap
⏱️ Updated: 20:21 · ⚠️ ~15 min delay
🏢 About AbbVie
AbbVie is a global biopharmaceutical company that spun off from Abbott Laboratories in 2013. Its blockbuster drug Humira held the title of world's best-selling medicine for many years before patent expiry. AbbVie has built a diversified portfolio through the acquisition of Allergan, adding Botox and other aesthetics products, as well as developing new immunology and oncology drugs such as Skyrizi and Rinvoq.
📈 30-day price history
| Date | Close | Volume |
|---|---|---|
| 22 Oct | $284.80 | 4,391,916 |
| 21 Oct | $289.08 | 5,173,961 |
| 20 Oct | $282.68 | 3,986,994 |
| 19 Oct | $285.42 | 5,638,833 |
| 16 Oct | $283.40 | 7,379,813 |
| 15 Oct | $283.48 | 5,623,920 |
| 14 Oct | $274.36 | 6,408,788 |
| 13 Oct | $281.12 | 5,493,801 |
| 12 Oct | $276.47 | 4,263,014 |
| 09 Oct | $272.42 | 4,301,279 |
| 08 Oct | $271.36 | 5,475,359 |
| 07 Oct | $266.69 | 4,500,656 |
| 06 Oct | $265.76 | 7,540,753 |
| 05 Oct | $262.82 | 5,541,012 |
| 02 Oct | $259.93 | 3,846,203 |
| 01 Oct | $261.59 | 4,311,051 |
| 30 Sep | $263.29 | 3,947,023 |
| 29 Sep | $266.28 | 4,393,401 |
| 28 Sep | $264.34 | 2,524,237 |
| 25 Sep | $265.12 | 3,430,526 |
| 24 Sep | $265.08 | 3,445,541 |
| 23 Sep | $265.21 | 2,757,784 |
| 22 Sep | $264.48 | 3,262,497 |
| 21 Sep | $263.96 | 8,000,296 |
| 18 Sep | $264.02 | 3,464,336 |
| 17 Sep | $262.51 | 3,117,811 |
| 16 Sep | $263.04 | 5,110,848 |
| 15 Sep | $261.77 | 4,454,152 |
| 14 Sep | $257.12 | 4,307,736 |
| 11 Sep | $255.00 | 4,393,091 |